Modulation of Blood Pressure by Central Melanocortinergic Pathways

Greenfield, Jerry R., Miller, Jeffrey W., Keogh, Julia M., Henning, Elana, Satterwhite, Julie H., Cameron, Gregory S., Astruc, Beatrice, Mayer, John P. +5 more·2009·New England Journal of Medicine

Cited by (490)

Items 401–490 of 490

  1. Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist
    Mark D. Ericson, Romessa Shaikh, Courtney M. Larson, Katie T. Freeman, Carrie Haskell‐Luevano · 2020 · ACS Medicinal Chemistry Letters
  2. GPCR’s and Endocrinology
    Caroline M. Gorvin · 2021 · Elsevier eBooks
  3. The effect of gender and obesity in modulating cross-bridge function in cardiac muscle fibers
    Jing Xi, Yuanchao Ye, Mohamad Mokadem, Jinxiang Yuan, Masataka Kawai · 2022 · Journal of Muscle Research and Cell Motility
  4. High resolution deep mutational scanning of the melanocortin-4 receptor enables target characterization for drug discovery
    Conor J Howard, Nathan S. Abell, Beatriz A. Osuna, Eric M. Jones, Leon Y Chan, Henry Chan, Dean R. Artis, Jonathan B Asfaha, Joshua S. Bloom, Aaron R. Cooper et al. · 2024 · eLife
  5. Dual Activation of MC3R and MC4R Drives Weight Loss and Reduces Food Intake in Obese Primates
    Jillian L. Seiler, Anna Chiara Impastato, E. Zhang, Kade J Kelley, Thomas L Bennett, Bradley Studnitzer, Claudia R. Prindle, Benjamin H. Rajewski, Barry A. Badeau, Xinjian Jiang et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Polikistik Over Sendromu ve Obezite: FTO ve MC4R Gen Polimorfizmlerinin Rolü
    Ayçıl Özturan-Şirin, Yasemin Akdevelıoğlu · 2020 · Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi
  7. Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors
    Samuel Gary, Anuradha Roy, Steven H. Bloom · 2024 · Journal of Peptide Science
  8. Exploratory safety investigations in normal, freely moving Göttingen Minipigs using telemetry: Pharmacological validation
    Julie Mie Jacobsen, Berit Østergaard Christoffersen · 2025 · Journal of Pharmacological and Toxicological Methods
  9. Recent developments in GPCR signalling in appetite regulation
    Holly R. Brittain, Caroline M. Gorvin · 2026 · Bioscience Reports
  10. Neural Control of Feeding and Energy Homeostasis
    Émilie Caron, Rexford S. Ahima · 2010 · Springer eBooks
  11. Hypertension and Type 2 Diabetes Mellitus in Children and Adolescents
    Charumathi Baskaran, Lynne L. Levitsky · 2018 · Elsevier eBooks
  12. Familial early-onset obesity in Turkish children: variants and polymorphisms in the melanocortin-4 receptor (MC4R) gene
    Heves Kırmızıbekmez, Yasemin Kendir Demirkol, Özlem Akgün Doğan, Gülcan Seymen Karabulut, Elif İnan Balcı, Pınar Atla, Fatma Dursun · 2022 · Journal of Pediatric Endocrinology and Metabolism
  13. Monogenic Obesity
    David Meyre, Philippe Froguel · 2010 · Springer eBooks
  14. Second Generation Anti-Obesity Medications
    Sri Nikhita Chimatapu, Steven D. Mittelman, Vibha Singhal · 2024 · Current Pediatrics Reports
  15. N-Branched Tricyclic Guanidines as Novel Melanocortin-3 Receptor Agonists and Melanocortin-4 Receptor Antagonists
    Nicholas A. Weirath, Jonathan W. P. Zajac, Haley M. Donow, Travis M. Lavoi, Clemencia Pinilla, Radleigh G. Santos, Ritu Prajapati, Robert Charles Speth, Mark D. Ericson, Sapna Sarupria et al. · 2025 · Journal of Medicinal Chemistry
  16. Modest Blood Pressure Increase with Age in Adults with Down’s Syndrome
    Andrea True Kelly, Meghan K. Shirley, Kate Fitzpatrick, Kat Adams, Ahtish Arputhan, Rachel Walega, Patricia Y. Chu, John Cockcroft, Raymond R. Townsend · 2025 · New England Journal of Medicine
  17. Blood pressure management in clinically complex scenarios: new horizons for a tailored approach
    Maria Concetta Pastore, Riccardo Liga, Enrico Emilio Diviggiano, Carlo B. Vitale, Alessandro Parlato, Francesca Amati, Flavio D’Ascenzi, Egidio Imbalzano, Andrea Rinaldi, Pietro Scicchitano et al. · 2025 · Journal of Hypertension
  18. Leptin, the Autonomic Nervous System, and Hypertension
    Alexandre A. da Silva, Jussara Marcia do Carmo, Zhen Wang, John Edward Hall · 2014 · Springer eBooks
  19. Obesity and Stress: The Melanocortin Connection
    Sara Singhal, Jennifer Wootton Hill · 2018 · Springer eBooks
  20. Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation
    Bas Brouwers, E M DE OLIVEIRA, Maria Martí-Solano, Fabiola Branco Filippin Monteiro, Suli‐Anne Laurin, Keogh JM, Elana Henning, Rebecca Bounds, Daly Ca, Shane Houston et al. · 2021 · Yearbook of pediatric endocrinology
  21. Melanocortinas y su participación en el desarrollo de la obesidad
    Verónica Elsa López-Alonso, Daniel Díaz‐Urbina, Rodrigo Erick Escartín-Pérez, Juan Manuel Mancilla Díaz · 2022 · Revista Mexicana de Trastornos Alimentarios/Mexican Journal of Eating Disorders
  22. Melanocortin-4-Receptor Autoantibodies: A New Player in Obesity
    Chandra Mohan, Anil K. Agarwal · 2009 · The Journal of Clinical Endocrinology & Metabolism
  23. Molecular investigation of genetic and environmental factors contributing to obesity in adolescent learners residing in the semi-urban/rural areas of the Western Cape Province, South Africa
    Yandiswa Yolanda Yako · 2012 · SUNScholar (Stellenbosch University)
  24. Obesity, insulin, and hypertension
    Jens Jordan · 2014 · Journal of Hypertension
  25. Food Intake, Circuitry, and Energy Metabolism
    Giles S.H. Yeo · 2016 · Wiley eBooks
  26. Impact of Obesity During Adulthood on Chronic Disease: Diabetes, Hypertension, Metabolic Syndrome, Cardiovascular Disease, and Cancer
    Jeanine Albu · 2012 · Wiley eBooks
  27. Human melanocortin-3 receptor: structure-function relationship of DPLIY motif and helix 8 and biased signaling
    Yang Zhao · 2016
  28. Genetic Obesity Syndromes
    Tinh‐Hai Collet, I. Sadaf Farooqi · 2019 · Wiley eBooks
  29. High resolution deep mutational scanning of the melanocortin-4 receptor enables target characterization for drug discovery
    Conor J Howard, Nathan S. Abell, Beatriz A. Osuna, Eric M. Jones, Leon Y Chan, Henry Chan, Dean R. Artis, Jonathan B Asfaha, Joshua S. Bloom, Aaron R. Cooper et al. · 2025 · eLife
  30. Neural mechanisms of sympathetic activation during hyperinsulinemia and obesity-induced hypertension
    Megan Elyse Bardgett · 2010 · UKnowledge (University of Kentucky)
  31. Le récepteur 4 aux mélanocortines, un paradigme de la génétique de l'obésité
    Fanny Stutzmann · 2009 · OpenGrey (Institut de l'Information Scientifique et Technique)
  32. Les déterminants de l'obésité et du surpoids chez les jeunes au Canada
    Jules Dessureault · 2010 · Archipel (Université du Québec à Montréal)
  33. Principles of Obesity Therapy
    Rexford S. Ahima · 2010 · Springer eBooks
  34. Hypertension in the Very Old: Special Features, Therapeutic Approaches, and Problems
    Athanase Bénétos, Ulrich M. Vischer, Ghassan Watfa · 2012 · Springer eBooks
  35. Letter by Landa et al Regarding Article, “Protein Tyrosine Phosphatase 1B, a Major Regulator of Leptin-Mediated Control of Cardiovascular Function”
    María Silvina Landa, Silvia Inés García, Carlos Jose Pirola · 2010 · Circulation
  36. The role of leptin in endothelial dysfunction and cardiovascular disease
    Gloria Millán García, Manuel O. Cruz · 2013
  37. Hypothalamic Melanocortin Regulation of Energy Balance and Metabolism
    Roxanne Dutia · 2012
  38. Monogenic Disorders Within the Energy Balance Pathway
    Ivy R. Aslan, Sayali A. Ranadive, Christian Vaisse · 2010 · Endocrine updates
  39. Cardiovascular Influences on Blood Pressure
    Albert P. Rocchini · 2013 · Humana Press eBooks
  40. Control of Appetite/Satiety and Energy Balance
    Joel Keith Elmquist, Jay D. Horton · 2015 · Wiley eBooks
  41. Modulation of Blood Pressure by Central Melanocortinergic Pathways
    W.J. Elliott · 2010 · Yearbook of Cardiology
  42. Essential Hypertension in Children: New Mechanistic Insights
    Anne‐Maj Samuelsson · 2016 · InTech eBooks
  43. Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Autonomic Dysfunction
    Radu Iliescu, Dragomir Nicolae Șerban · 2017 · Springer eBooks
  44. Discovery of Peptide and Peptidomimetic Based Ligands Targeting the Melanocortin Receptors: A campaign in mixture-based positional scanning, chemical topology, and structure-activity relationships
    Skye R. Doering · 2016 · University of Minnesota Digital Conservancy (University of Minnesota)
  45. Putting a brake on hunger
    I. Sadaf Farooqi · 2021 · Science
  46. Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort
    Kaitlin Hazel Wade, Brian Lam, Audrey Melvin, Pan W, Laura J. Corbin, Hughes Da, Kara Rainbow, Chen JH, Katie Duckett, Xia Liu et al. · 2021 · Yearbook of pediatric endocrinology
  47. Assessment of Obesity in Children
    I. Sadaf Farooqi · 2022
  48. Genetics of obesity
    Karine Clément · 2011
  49. Obesity
    Sohail Abdul Salim, Krishna Keri, Mohit Agarwal · 2020 · Springer eBooks
  50. Cardiovascular Influences on Blood Pressure
    Albert P. Rocchini · 2018 · Springer eBooks
  51. Role of the kidney in hypertension
    John Edward Hall, Jussara Marcia do Carmo, Alexandre A. da Silva, Zhen Wang, Michael E. Hall · 2013 · Hypertension
  52. Faculty Opinions recommendation of Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.
    Arun K. Shukla · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  53. Cardiovascular Influences on Blood Pressure
    Albert P. Rocchini · 2017 · Springer eBooks
  54. Genes Predisposing to Erectile Dysfunction and Management: A Review
    Tajudeen Yahaya, Esther Oluwasayo Oladele, Mutiu Oyekunle Sifau, Kasimu Shehu, Adamu Aliyu ALIERO, Tayo Bakare · 2022 · Serbian Journal of Experimental and Clinical Research
  55. Monogene Adipositas
    Julia von Schnurbein, Martin Wabitsch · 2022 · Springer eBooks
  56. Amphetamine Acts Through the Melanocortin System to Regulate Metabolism and Cardiovascular Function
    Stephanie E. Simonds, Jack T. Pryor, Brian Lam, Georgina K.C. Dowsett, Tomris Mustafa, Astrid C Munder, Kayla Elysee, Églantine Balland, Lachlan O. Cowley, Giles S.H. Yeo et al. · 2022 · SSRN Electronic Journal
  57. A comparative study on obese and non-obese for evaluating the risk of hypertension
    Shaik Mahmood, D Santha Rao · 2022 · International Journal of Clinical Biochemistry and Research
  58. Is there any Relationship between Body Weight and Urine Ketones?
    Hussain HS · 2019 · Annals of Immunology & Immunotherapy
  59. Syndromic and Monogenic Obesity
    Molly X. Nguyen, Logan Danner, Vidhu Thaker · 2023 · Springer eBooks
  60. Genetics of Obesity
    I. Sadaf Farooqi · 2024 · Wiley eBooks
  61. Management of Obesity Disorders in Childhood and Adolescence
    Peter Kühnen · 2023 · Endocrinology
  62. Genetic Variants Connected to the Obesity
    Md. Shafiul Hossen, Md Abdul Barek, Mohammad Safiqul Islam · 2024 · Springer eBooks
  63. Management of Obesity Disorders in Childhood and Adolescence
    Peter Kühnen · 2024 · Endocrinology
  64. Targeting the hypothalamic MC4 receptor: A novel approach to senolytic therapy?
    Youn Ju Kim, Joo Hyun Lim, Eun Ran Kim · 2024 · Medical Hypotheses
  65. Melanocortin Signaling in the Carotid Body as a Putative Cause of Hypertension
    Mateus R. Amorim, Vsevolod Y. Polotsky · 2025 · Circulation Research
  66. Additional file 1 of Are there any interactions between modified Nordic-style diet score and MC4R polymorphism on cardiovascular risk factors among overweight and obese women? A cross-sectional study
    Hosseininasab, Dorsa, Atieh Mirzababaei, Faezeh Abaj, Firoozi, Roya, Cain C. T. Clark, Khadijeh Mirzaei · 2022 · Figshare
  67. Additional file 1 of PDX1 and MC4R genetic polymorphisms are associated with type 2 diabetes mellitus risk in the Chinese Han population
    Ning Wang, Tong, Rui, Xu, Jing, Yanni Tian, Pan, Juan, Cui, Jiaqi, Chen, Huan, Yanqi Peng, Fei, Sijia, Yang, Shujun et al. · 2021 · Figshare
  68. MC4R Deficiency
    Ozair Abawi, Lotte Kleinendorst · 2025 · Springer eBooks
  69. Implication des neurones exprimant NUCB2/nesfatine-1 dans la régulation de l'homéostasie énergétique
    Marion S. Bonnet · 2013 · theses.fr (ABES)
  70. Impact of LYL1 deficiency on adipocyte differentiation
    Abid Hussain · 2015
  71. Rationale of renewed efforts in developing MC4R modulators to treat metabolic disorders
    Wenbo Feng, Qingtong Zhou, Ming‐Wei Wang · 2026 · Acta Pharmaceutica Sinica B
  72. Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system
    John Edward Hall, Ana Carolina Mieko Omoto, Jussara Marcia do Carmo, Alexandre A. da Silva, Alan J. Mouton, Zhen Wang, Michael E. Hall · 2026 · Clinical Science
  73. The Synthetic Melanocortin Agonist NDP ‐ MSH Ameliorates THSD 7 A ‐Associated Membranous Nephropathy in an Active Immunization Mouse Model
    Mingzhuo Zhang, Mengxuan Chen, Yan Ge, William Gunning, Rujun Gong · 2026 · The FASEB Journal
  74. Small molecule ligands for the melanocortin-4 receptor: pharmacology, biased signaling, and pharmacoperone potential
    Ya‐Xiong Tao, Renlei Ji · 2026 · Molecular and Cellular Endocrinology
  75. Impact of setmelanotide on metabolic syndrome risk in patients with proopiomelanocortin or leptin receptor deficiencies
    S. Brandt, I. Sadaf Farooqi, Wendy K. Chung, Erica L T van den Akker, Peter Kühnen, James M. Swain, Jill Garrison, Nicolas Touchot, Jesús Argente, Karine Clément · 2026 · The Journal of Clinical Endocrinology & Metabolism
  76. BindingDB Entry 50014427: Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput "Unbiased" Screening Campaign.
    BindingDB · 2022 · UC San Diego
  77. BindingDB Entry 50014265: Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist.
    BindingDB · 2022 · UC San Diego
  78. BindingDB Entry 50007656: Single Nucleotide Polymorphisms in the Melanocortin His-Phe-Arg-Trp Sequences Decrease Tetrapeptide Potency and Efficacy.
    BindingDB · 2021 · UC San Diego
  79. BindingDB Entry 50006524: Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor.
    BindingDB · 2020 · UC San Diego
  80. BindingDB Entry 50046729: A fragment of the Escherichia coli ClpB heat-shock protein is a micromolar melanocortin 1 receptor agonist.
    BindingDB · 2016 · UC San Diego
  81. BindingDB Entry 50047392: An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.
    BindingDB · 2017 · UC San Diego
  82. BindingDB Entry 50000432: Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists.
    BindingDB · 2019 · UC San Diego
  83. BindingDB Entry 50023415: N-Branched Tricyclic Guanidines as Novel Melanocortin-3 Receptor Agonists and Melanocortin-4 Receptor Antagonists.
    BindingDB · 2026 · UC San Diego
  84. BindingDB Entry 50007962: Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.
    BindingDB · 2021 · UC San Diego
  85. BindingDB Entry 50045775: Melanocortin antagonist tetrapeptides with minimal agonist activity at the mouse melanocortin-3 receptor.
    BindingDB · 2016 · UC San Diego
  86. BindingDB Entry 50042549: Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse melanocortin-4 receptor (mMC4R).
    BindingDB · 2013 · UC San Diego
  87. BindingDB Entry 50048982: A Macrocyclic Agouti-Related Protein/[Nle
    BindingDB · 2019 · UC San Diego
  88. BindingDB Entry 50006771: Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors.
    BindingDB · 2021 · UC San Diego
  89. BindingDB Entry 50011659: Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist.
    BindingDB · 2022 · UC San Diego
  90. BindingDB Entry 50033095: Incorporation of a bioactive reverse-turn heterocycle into a peptide template using solid-phase synthesis to probe melanocortin receptor selectivity and ligand conformations by 2D 1H NMR.
    BindingDB · 2011 · UC San Diego